The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(4-Chlorobenzyl)-1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide ID: ALA2063867
PubChem CID: 57522926
Max Phase: Preclinical
Molecular Formula: C24H35ClN4O3
Molecular Weight: 463.02
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCc1ccc(Cl)cc1)C1CCCCC1
Standard InChI: InChI=1S/C24H35ClN4O3/c1-16(26-2)22(30)28-21(18-7-4-3-5-8-18)24(32)29-14-6-9-20(29)23(31)27-15-17-10-12-19(25)13-11-17/h10-13,16,18,20-21,26H,3-9,14-15H2,1-2H3,(H,27,31)(H,28,30)/t16-,20-,21-/m0/s1
Standard InChI Key: MNWPVYOXWIATDM-NDXORKPFSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
11.5875 -11.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3020 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8110 -11.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3064 -12.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7715 -12.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5632 -12.5663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3020 -10.5042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0164 -11.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0164 -12.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7309 -11.3292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4454 -11.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4454 -12.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1599 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8743 -11.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1599 -10.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4010 -10.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8160 -10.0342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5760 -10.7443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1610 -11.4573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5888 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3020 -12.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3000 -13.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0126 -14.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7289 -13.7984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7326 -12.9708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3360 -11.4544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9304 -10.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1061 -10.7318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6903 -11.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1047 -12.1637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9276 -12.1634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8653 -11.4435 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3 16 1 1
2 8 1 0
16 17 2 0
16 18 1 0
8 9 1 1
18 19 1 0
3 4 1 0
14 20 1 0
9 21 1 0
8 10 1 0
4 5 1 0
10 11 1 0
5 6 1 0
11 12 2 0
9 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
6 1 1 0
19 26 1 0
11 13 1 0
26 27 2 0
1 2 1 0
27 28 1 0
13 14 1 0
28 29 2 0
2 7 2 0
29 30 1 0
13 15 1 6
30 31 2 0
31 26 1 0
1 3 1 0
29 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 463.02Molecular Weight (Monoisotopic): 462.2398AlogP: 2.62#Rotatable Bonds: 8Polar Surface Area: 90.54Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.53CX Basic pKa: 8.60CX LogP: 2.56CX LogD: 1.33Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -0.77
References 1. Flygare JA, Beresini M, Budha N, Chan H, Chan IT, Cheeti S, Cohen F, Deshayes K, Doerner K, Eckhardt SG, Elliott LO, Feng B, Franklin MC, Reisner SF, Gazzard L, Halladay J, Hymowitz SG, La H, LoRusso P, Maurer B, Murray L, Plise E, Quan C, Stephan JP, Young SG, Tom J, Tsui V, Um J, Varfolomeev E, Vucic D, Wagner AJ, Wallweber HJ, Wang L, Ware J, Wen Z, Wong H, Wong JM, Wong M, Wong S, Yu R, Zobel K, Fairbrother WJ.. (2012) Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)., 55 (9): [PMID:22413863 ] [10.1021/jm300060k ]